Abiopharma

Une nouvelle étude de MetLife révèle un « déficit de confiance » de 72 % quant à la capacité à se remettre des épreuves de la vie

Novo estudo da MetLife revela uma "lacuna de confiança" de 72% na capacidade de se recuperar dos reveses da vida

Eine neue Studie von MetLife deckt eine „Vertrauenslücke“ von 72 % hinsichtlich der Fähigkeit auf, Rückschläge im Leben zu überwinden

Un nuevo estudio de MetLife revela una “falta de confianza” del 72% en la capacidad para recuperarse de los reveses de la vida

BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT™

Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management

PHINIA Inc. to Report Q2 2026 Earnings

Q2 Metals Commences Summer Drill Program and Advances Toward PEA on the Cisco Lithium Project in Quebec, Canada

Prairie Operating Co. Appoints Gregory S. Patton Chief Executive Officer and Director and Michael J. Shelly Chief Financial Officer

Wingstop Elevates its Summer Flavor Game with New Sweet Heat Chamoy Featuring Tajín